Trump says he’ll drop prescription drug prices 30-80%
President Donald Trump has announced his plans to sign an executive order this week that he claims will drastically reduce the cost of prescription drugs and pharmaceuticals by between 30% to 80% almost immediately. The announcement was made on Truth Social Sunday, where Trump expressed his frustration over the exorbitant prices of medications in the United States compared to other nations.
In a statement, Trump questioned why prescription drugs in the US were priced so much higher than in other countries, despite being manufactured in the same facilities by the same companies. He criticized the pharmaceutical industry for attributing the high costs to research and development expenses, which he believed were unfairly burdening American consumers. Trump vowed to take action to address this disparity, emphasizing that campaign contributions would not influence his decision-making.
“We are going to do the right thing, something that the Democrats have fought for many years,” Trump declared. “Therefore, I am pleased to announce that Tomorrow morning, in the White House, at 9:00 A.M., I will be signing one of the most consequential Executive Orders in our Country’s history. Prescription Drug and Pharmaceutical prices will be REDUCED, almost immediately, by 30% to 80%.”
The president revealed that the executive order would implement a “Most Favored Nation’s Policy,” ensuring that the United States pays the same price for drugs as the nation with the lowest prices worldwide. This policy is aimed at bringing fairness to America and reducing healthcare costs for its citizens significantly. Trump also emphasized that the US would save trillions of dollars through these cost reductions.
While acknowledging that drug prices may increase globally as a result of these changes, Trump maintained that it was essential to prioritize fairness for American consumers. The executive order is expected to have a substantial impact on the healthcare industry and could mark a significant shift in how prescription drugs are priced and accessed in the US.
The announcement has generated significant interest and anticipation, with many eagerly awaiting the implementation of the executive order. Trump’s initiative to address the high cost of prescription drugs aligns with his administration’s commitment to improving healthcare affordability and accessibility for all Americans. The president’s decision to take action on this issue reflects his determination to prioritize the needs of the American people above all else.
